Parkin and mitochondria in methamphetamine use disorder

A postdoctoral fellow position is available in the laboratory of Anna Moszczynska, Ph.D., to study cellular and molecular mechanisms underlying the anti-addictive properties of protein parkin in methamphetamine use disorder. Methamphetamine use disorder is a disorder without FDA-approved medication in need of new drug targets. Ubiquitin-protein ligase parkin is one of potential drug targets. The laboratory uses a rat model of methamphetamine use disorder and a variety of behavioral, molecular biology, and imaging methods in her research.

The postdoctoral fellow will work in a collaborative and friendly laboratory with the PI who is strongly committed to mentoring young scientists.

• Ph.D.
• A strong background in a neuroscience-related discipline, such as neuropharmacology, molecular neurobiology, neurophysiology, or behavioral neuroscience.
• A publication track record.
• Hands-on experience working with rats or mice is required.
• Prior experience with rat models of drug self-administration is preferred but not required. Candidates with the drug self-administration experience will be given preference.

Email

CV, personal statement on your research experience and career goals, and contact information for 3 references toamosz .